TSUMURA & CO.

4540

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-06FY2027 Q1

Revenue

1992.3100M JPY

YoY +10.4%

Operating Income

78.8100M JPY

YoY +2.1%

Net Income

302.1100M JPY

YoY +17.9%

EPS

86.6JPY

YoY +49.0%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

1926.2億円

1444.6億円

963.1億円

481.5億円

Rev: 1295.5億円Op: 223.8億円NI: 188.4億円

Rev: 1400.4億円Op: 209.2億円NI: 164.8億円

Rev: 1508.5億円Op: 200.2億円NI: 167.1億円

Rev: 1810.9億円Op: 401.3億円NI: 324.3億円

Rev: 1926.2億円Op: 352.2億円NI: 281.2億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income24.6%

Revenue Progress49700M

Revenue Forecast213600M

Net Income Progress64.600M

Net Income Forecast26200M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan